Comments on “ Effect of platelet storage duration on platelet increment and clinical outcomes in critically ill patients – A randomised controlled trial” - 12/03/25

Highlights |
• | The sample size estimation was based on local transfusion needs rather than a broader population, raising concerns about the accuracy and generalizability of the findings. |
• | Inclusion of ICU patients without baseline diagnostic details may introduce variability that could affect the study’s outcomes. |
• | The non-blinded design, where authors and participants were aware of interventions, could have influenced platelet transfusion decisions. |
• | The study does not specify criteria for platelet transfusion, making it difficult to assess the consistency and applicability of treatment decisions. |
Abstract |
The randomized trial by Muraleedharan et al. explored the optimal duration of platelet concentrate storage, concluding that storage duration has no clinical relevance. While the study provides novel insights, we identified two methodological concerns. First, the sample size estimation was based on local transfusion needs rather than a broader population, potentially affecting effect estimation and generalizability. Additionally, the study’s inclusion of intensive care unit (ICU) patients may introduce heterogeneity that is not accounted for in a small study population. Second, the absence of clear criteria for platelet transfusion, coupled with the non-blinded study design, raises concerns about potential bias in treatment decisions. Addressing these limitations in future research will improve the validity and applicability of findings.
Le texte complet de cet article est disponible en PDF.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?